Market Overview:
The global in-vitro diagnostics (IVD) devices market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing incidence of chronic diseases, rising demand for point-of-care testing, and technological advancements in IVD devices. Based on type, the global IVD devices market is segmented into clinical chemistry analysers, intravenous medical devices, test strips, and other types. The clinical chemistry analysers segment is expected to account for the largest share of the global IVD devices market in 2018. This segment is also projected to grow at a CAGR of 6.8% during the forecast period from 2018 to 2030.
 Devices Industry Outlook.svg)
Product Definition:
IVD devices are used to diagnose diseases or conditions in a laboratory setting. They can be used to test blood, tissue, or other bodily fluids for the presence of certain substances or abnormalities. IVD devices are important for diagnosing diseases and conditions early, which can improve the chances of a successful treatment.
Clinical Chemistry Analyser:
The global clinical chemistry analyzer market size was valued at USD 4.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period due to its increasing demand in point-of-care testing, rising prevalence of chronic diseases, and growing geriatric population base.
Intravenous Medical Devices:
Intravenous medical devices are used in the diagnosis of diseases by delivering medicines and fluids directly into the blood vessels. These IVDs help healthcare professionals to measure and monitor substances such as glucose, urea, electrolytes, proteins, hormones etc. They also enable the administration of vaccines or drugs that cannot be given orally or by inhalation.
The global intravenous medical devices & it's usage in IVD market was valued at USD 32 billion in 2015.
Application Insights:
The application segment includes clinical laboratories, diagnostic centers and other applications. The other applications include hospitals and clinics, home healthcare services, and point-of-care settings. The growth of the latter two segments is attributed to the increasing usage of in-vitro diagnostics devices at these facilities for testing patients¢â‚¬â„¢ blood samples.
Clinical laboratories accounted for a revenue share of over 60% in 2017 owing to high usage rates of these devices across various lab settings such as hospital & clinical laboratory complexes, research organizations & government institutes, commercial labs., etc. In addition, an increase in demand for rapid testing by regulatory authorities such as FDA is expected to boost product adoption over the forecast period.
Regional Analysis:
North America dominated the global IVD devices market in 2017. This can be attributed to the presence of key players, high disposable income, and availability of advanced products. The region is expected to maintain its dominance throughout the forecast period owing to factors such as favorable government policies and increasing demand for technologically advanced medical testing equipment & solutions. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to an increase in healthcare expenditure by governments along with rising awareness about early diagnosis among people.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. This has led to a surge in the demand for diagnostic tests, which in turn is fueling the growth of the IVD devices market.
- Technological advancements: The IVD devices market is witnessing rapid technological advancements, with manufacturers introducing new and innovative products into the market. This is helping to boost demand for these devices and driving their growth.
- Rising awareness about preventive healthcare: There has been a growing awareness among people about preventive healthcare measures in recent years, which has led to an increase in demand for diagnostic tests. This is benefiting the IVD devices market significantly.
Scope Of The Report
Report Attributes
Report Details
Report Title
In-Vitro Diagnostics (IVD) Devices Market Research Report
By Type
Clinical Chemistry Analyser, Intravenous Medical Devices, Test Strips, Other
By Application
Clinical Laboratories, Diagnostic Centers
By Companies
BD, Abbott, Danaher, Hologic, BioMerieux, Cepheid, Quidel, Roche Diagnostics, Siemens Healthcare, Sysmex, BMP Medical, TUV Rheinland
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global In-Vitro Diagnostics (IVD) Devices Market Report Segments:
The global In-Vitro Diagnostics (IVD) Devices market is segmented on the basis of:
Types
Clinical Chemistry Analyser, Intravenous Medical Devices, Test Strips, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Laboratories, Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- Abbott
- Danaher
- Hologic
- BioMerieux
- Cepheid
- Quidel
- Roche Diagnostics
- Siemens Healthcare
- Sysmex
- BMP Medical
- TUV Rheinland
 Devices Market Overview.svg)
Highlights of The In-Vitro Diagnostics (IVD) Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Clinical Chemistry Analyser
- Intravenous Medical Devices
- Test Strips
- Other
- By Application:
- Clinical Laboratories
- Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In-Vitro Diagnostics (IVD) Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Devices Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
IVD devices are medical equipment used to diagnose and treat diseases in vitro. This means that the devices are not used on humans, but instead they are used in a laboratory setting to study how diseases work and how they can be treated. IVD devices can include everything from blood tests to surgery tools.
Some of the major companies in the in-vitro diagnostics (ivd) devices market are BD, Abbott, Danaher, Hologic, BioMerieux, Cepheid, Quidel, Roche Diagnostics, Siemens Healthcare, Sysmex, BMP Medical, TUV Rheinland.
The in-vitro diagnostics (ivd) devices market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In-Vitro Diagnostics (IVD) Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. In-Vitro Diagnostics (IVD) Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. In-Vitro Diagnostics (IVD) Devices Market - Supply Chain
4.5. Global In-Vitro Diagnostics (IVD) Devices Market Forecast
4.5.1. In-Vitro Diagnostics (IVD) Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. In-Vitro Diagnostics (IVD) Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. In-Vitro Diagnostics (IVD) Devices Market Absolute $ Opportunity
5. Global In-Vitro Diagnostics (IVD) Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Type
5.3.1. Clinical Chemistry Analyser
5.3.2. Intravenous Medical Devices
5.3.3. Test Strips
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global In-Vitro Diagnostics (IVD) Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Application
6.3.1. Clinical Laboratories
6.3.2. Diagnostic Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global In-Vitro Diagnostics (IVD) Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global In-Vitro Diagnostics (IVD) Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global In-Vitro Diagnostics (IVD) Devices Demand Share Forecast, 2019-2026
9. North America In-Vitro Diagnostics (IVD) Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Application
9.4.1. Clinical Laboratories
9.4.2. Diagnostic Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Type
9.7.1. Clinical Chemistry Analyser
9.7.2. Intravenous Medical Devices
9.7.3. Test Strips
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America In-Vitro Diagnostics (IVD) Devices Demand Share Forecast, 2019-2026
10. Latin America In-Vitro Diagnostics (IVD) Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Application
10.4.1. Clinical Laboratories
10.4.2. Diagnostic Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Type
10.7.1. Clinical Chemistry Analyser
10.7.2. Intravenous Medical Devices
10.7.3. Test Strips
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America In-Vitro Diagnostics (IVD) Devices Demand Share Forecast, 2019-2026
11. Europe In-Vitro Diagnostics (IVD) Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Application
11.4.1. Clinical Laboratories
11.4.2. Diagnostic Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Type
11.7.1. Clinical Chemistry Analyser
11.7.2. Intravenous Medical Devices
11.7.3. Test Strips
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe In-Vitro Diagnostics (IVD) Devices Demand Share, 2019-2026
12. Asia Pacific In-Vitro Diagnostics (IVD) Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Application
12.4.1. Clinical Laboratories
12.4.2. Diagnostic Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Type
12.7.1. Clinical Chemistry Analyser
12.7.2. Intravenous Medical Devices
12.7.3. Test Strips
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific In-Vitro Diagnostics (IVD) Devices Demand Share, 2019-2026
13. Middle East & Africa In-Vitro Diagnostics (IVD) Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Application
13.4.1. Clinical Laboratories
13.4.2. Diagnostic Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa In-Vitro Diagnostics (IVD) Devices Market Size and Volume Forecast by Type
13.7.1. Clinical Chemistry Analyser
13.7.2. Intravenous Medical Devices
13.7.3. Test Strips
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa In-Vitro Diagnostics (IVD) Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global In-Vitro Diagnostics (IVD) Devices Market: Market Share Analysis
14.2. In-Vitro Diagnostics (IVD) Devices Distributors and Customers
14.3. In-Vitro Diagnostics (IVD) Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BD
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hologic
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BioMerieux
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cepheid
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Quidel
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Roche Diagnostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Siemens Healthcare
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sysmex
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. BMP Medical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. TUV Rheinland
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
